Back to REGN
NORTH POINT PORTFOLIO MANAGERS CORP/OH → REGN
NORTH POINT PORTFOLIO MANAGERS CORP/OH REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$12.2M
Q3 2026
Peak value
$12.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9.4M |
| Q4 2025 | $12.9M |
| Q1 2026 | $12.9M |
| Q2 2026 | $10.2M |
| Q3 2026 | $12.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $12.2M | 16.1K | — | — |
| Q2 2026 | $10.2M | 16.4K | — | — |
| Q1 2026 | $12.9M | 16.7K | — | — |
| Q4 2025 | $12.9M | 16.7K | — | — |
| Q3 2025 | $9.4M | 16.7K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B